Substance Use Programs
Contact an Expert
Shawn Billings
Vice President of Substance Use Programming
- Send an Email
- 573-893-3700| ext. 1409
Strengthening Substance Use Disorder Programs in Missouri Hospitals
Hospitals and health care advocates play an essential role in reducing substance use disorders and improving patient outcomes. SUD is a treatable mental disorder that affects a person’s brain and behavior, leading to an inability to control their use of substances such as legal or illegal drugs, alcohol, nicotine and e-cigarettes, or medications.
Reliance on these substances poses significant public health concerns for both adults and youth, including addictive behaviors, overdoses, long-term health issues and even death.
MHA seeks to assist Missouri hospitals in these efforts through research, resources, and comprehensive, patient-centered strategies. Through education and implementation of these programs, hospitals can expand prevention, treatment, and recovery support services for opioids, nicotine, and other misused substances.
What’s on this page
Quickly Navigate to the Information You’re Looking for
Barriers to Effective SUD Treatment
While effective treatment can lead to long-term remission, nearly 80% of individuals with SUD do not receive care, according to the Substance Abuse and Mental Health Services Administration. Barriers to treatment include stigma, fragmented care systems and limited access to evidence-based interventions.
Addressing substance use disorders requires tackling multiple systemic challenges, including:
- Limited access to health and behavioral health care services
- Inaccessible SUD treatment programs due to financial and geographic barriers
- Prescribing practices that may contribute to opioid dependency
- Social determinants of health, such as homelessness, unemployment and poverty
Missouri’s substance use crisis demands a coordinated, public health-driven approach that expands community resources and improves access to timely, evidence-based care.
Missouri Initiatives to Address Substance Use Disorders
Several statewide initiatives are working to improve access to integrated prevention, treatment and recovery support services. Key efforts include:
- Multidisciplinary training for providers and community members on opioid overdose prevention and naloxone distribution
- Increased patient access to pharmacotherapies, such as buprenorphine, through enhanced clinician education
- SUD treatment engagement programs to improve early intervention and sustained recovery
- Patient care navigation services that support safe and timely transitions between levels of care
By strengthening hospital-based programs and collaborating with community partners, Missouri’s health care system can play a pivotal role in reducing substance use disorders and improving long-term health outcomes.
Current Opioid Prescribing Guidance
Missouri hospitals play a key role in ensuring responsible opioid prescribing to prevent misuse and support effective pain management. To guide hospital-based physicians, a coalition of health care policy and advocacy organizations has developed opioid prescribing recommendations that reflect evolving best practices and changes in state and federal laws.
CDC Opioid Prescribing Recommendations
The Centers for Disease Control and Prevention has issued guidelines for prescribing opioid medications for chronic pain, excluding cancer, palliative and end-of-life care. These recommendations help providers:
- Assess risks and benefits of opioid therapy
- Set clear treatment goals to ensure patient safety
- Use non-opioid and non-pharmacologic therapies when possible
By following state and national prescribing guidelines, Missouri hospitals can reduce opioid dependency and improve patient and community safety.
Resources for Safe Opioid Use & Treatment
MHA has gathered a collection of evidence-based guidelines, best practices, and implementation strategies to help hospitals and health care providers improve opioid prescribing, pain management, and substance use treatment. These resources support efforts to enhance patient care and reduce opioid-related harm.
Implementing Overdose Education in Emergency Departments
MHA’s guide helps hospitals integrate Emergency Department-Initiated Overdose Education and Naloxone Distribution programs to reduce opioid-related harm. This resource outlines key considerations and strategies for implementing a cost-effective, life-saving intervention for at-risk community members.
Additional Tools for Opioid Misuse Reduction Hospital Flyers
Current Smoking Cessation Guidance
Vaping and electronic nicotine use have surged in recent years, particularly among youth, raising serious public health concerns. MHA provides guidance and resources to promote policies, prevention efforts, and treatment options amid rising cases of smoking and vaping-related illnesses.
Policy Guides
Supporting Smoke-Free Policies in Missouri Hospitals
Hospitals play a vital role in promoting public health and reducing tobacco-related harm. Implementing smoke-free policies helps create healthier environments for patients, staff and visitors.
National Efforts to Strengthen Smoke-Free Policies
The American Nonsmokers’ Rights Foundation highlights the ongoing impact of secondhand smoke exposure and the need for stronger smoke-free policies nationwide. Missouri is specifically noted due to its lack of workplace protections for employees in casino settings.
The foundation provides sample smoke-free policies for various settings, along with guidance on enforcement strategies, to help organizations implement effective tobacco-free policies that protect workers and patrons.
By adopting comprehensive smoke-free policies, Missouri hospitals can lead efforts to reduce tobacco-related illnesses and promote long-term health improvements.
Helpful Resources Health Advisories & Research on Vaping-Related Risks
Growing concerns over vaping-related illnesses have led to multiple health advisories and research findings highlighting its dangers. The Missouri Department of Health and Senior Services and the CDC have issued warnings about severe lung disease linked to vaping, while studies from Stanford Medicine, the Israel Cancer Association, and the University of North Carolina reveal risks to heart health, brain stem cells, and lung function. Ongoing FDA and CDC investigations continue to track vaping-related illnesses and provide updates on consumer safety.
The following health advisories and research can be used to educate health care communities and patient populations to promote cessation efforts.
- Missouri Department of Health and Senior Services Health Advisory: Severe Lung Disease Associated With Vaping
- Centers for Disease Control and Prevention Health Advisory: Severe Pulmonary Disease Associated With Using E-Cigarette Products
- CDC: Outbreak of Electronic Cigarette Associated Acute Lipoid Pneumonia
- Stanford Medicine: E-cigarette Use, Flavorings May Increase Heart Disease Risk
- Israel Cancer Association: Vaping Impacts Brain Stem Cells
- University of North Carolina Study: The Impact on the Lungs Due to Chronic E-Cigarette Use
- U.S. Food & Drug Administration: Vaping Illnesses: Consumers Can Help Protect Themselves by Avoiding THC-Containing Vaping Products